Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Ruxolitinib Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/02/2021 10 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Amodiaquine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/12/2021 6 0
Leucovorin Potential treatment - theoretical effect Used to treat other disease Antiviral Jan/18/2021 2 0
Mefloquine hydrochloride Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 8 0
Chlorpromazine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 3 0
Mitoxantrone Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/04/2020 2 0
Excel (.xslx) CSV (.csv)